Cardiex specializes in the development of biomarkers and digital solutions for large-scale cardiovascular health disorders
Our Solutions
Our solutions are designed to be deployed at point-of-care for arterial health screening, and as part of a remote patient monitoring regimen to extend care and improve cardiovascular health outcomes.
Spotlight
Dr. Joseph Raffaele
Longevity Medicine Specialist
Utilizing digital biomarkers to improve cardiovascular health of patients
Our FDA-cleared technology replaces traditional blood pressure technology as the first-line screening and monitoring of arterial health.
Risk Stratification: Evaluate arterial health and identify those who may be at greater risk of cardiovascular, metabolic, renal, and neurological diseases.
Early Detection of Disease Onset: Stiffening of arteries are an early indicator of disease onset.
Monitoring Progression: Regular assessments track changes over time to signal improvement or worsening disease progression.
Treatment Evaluation: Assess the efficacy of pharmacological and lifestyle interventions.
Spotlight Trial
CARTESIAN Study
Artery Society